Sinus Dilation Devices Market Report-Forecast till 2027

Sinus Dilation Devices Market Research Report by Product (Sinus Stents, Balloon Dilation, Endoscope), Procedure (Hybrid Sinus Dilation), Patient Type (Pediatric, Adults), End-User (Hospitals, ENT Clinics, and Others)-Forecast till 2027

ID: MRFR/MED/5181-HCR | November 2022 | Region: Global | 90 Pages         

Sinus Dilation Devices Market

The Sinus Dilation Devices Market is expected to reach USD 5,777.5 million, at a CAGR of 8.5% from 2020 to 2027

Segmentation

By Product Sinus Stents Balloon Dilation Endoscope
By Procedure Hybrid Sinus Dilation
By Patient Type Pediatric Adults

Key Players

  • Sklar Surgical Instruments (US)
  • Accurate Surgical & Scientific Instruments (USA)
  • Bausch & Lomb Incorporated (US)
  • Entellus Medical Inc. (a subsidiary of Stryker) (US)
  • Acclarent Inc.

Drivers

  • Growing respiratory tract infection
Speak to Analyst Request a Free Sample

Sinus Dilation Devices Market Overview:


From 2020 to 2027, the Sinus Dilation Devices Market is predicted to grow at an annual rate of 8.5 percent, reaching USD 5,777.5 million. Sinusitis is a medical illness that causes swelling and obstruction of the nose, preventing significant mucus discharge. Sinus dilation devices are used to treat sinus disorders and nasal difficulties by expanding the sinus passages. According to data from the American College of Physicians from March 2016, 4.3 million people are diagnosed with sinusitis each year. The rise in the frequency of chronic sinusitis, the rise in respiratory tract infection, the rise in patient desire for less invasive operations, and the rise in technical breakthroughs in sinus dilation devices are all drivers driving this market. Furthermore, factors such as the advantages of sinus dilation/balloon sinuplasty over standard sinus procedures are expected to boost market growth throughout the anticipated period.


Segmentation


The Sinus Dilation Devices Market is segmented on the basis of product, procedure, by patient type and end-user. The sinus dilation devices market, by product is segmented into sinus stents, balloon dilation, endoscope, functional endoscopic sinus surgery (FESS) instruments set, and handheld instruments. The endoscope is sub segmented into rhinoscopy and sinoscopy.      


By procedure the sinus dilation devices market is segmented into hybrid sinus dilation procedure, standalone sinus dilation procedures, and others.  


On the basis of patient type, the market is segmented into pediatric and adults.


On the basis of end-user, the market is segmented into hospitals, ENT clinics, diagnostic centers, research centers, and others.


On the basis of region, the global sinus dilation devices market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa. 


Sinus Dilation Devices Market Key Players


Some of the key players in the global sinus dilation devices market are Sklar Surgical Instruments (US), Accurate Surgical & Scientific Instruments (USA), Bausch & Lomb Incorporated (US), Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), Olympus Corporation (Japan), Meril Life, Sciences Pvt. Ltd. (India), SinuSys Corporation (US), Jilin Coronado Medical Ltd. (China), and others. 


Regional Market Summary


Global Sinus Dilation Devices Market Share (%), by Region, 2017 Global Sinus Dilation Devices Market Share (%), by Region, 2017


Sources: National Cancer Institute, Cancer research UK, the American Cancer Society, Inc., US Department of Health and Human Services National Institutes of Health


It is estimated that North America dominated the global sinus dilation devices market owing to the increasing in the prevalence of chronic sinusitis. According to the Centers for Disease Control and Prevention chronic sinusitis 2017 data 26.9 million adults were diagnosed with sinusitis in the US.  Such a high number of sinusitis patients may support the market growth during the forecasted period.


Europe stood second largest market owing to the increasing number of patients with bacterial infection causing respiratory problems and sinus. According to the European Lung white book 2018, the occurrence of acute bronchitis in people is growing, between 30 and 50 per 1000 person every year is suffering from bronchitis problem. It means that Europe, accounts approximately 16,500,000 cases for primary treatment. Such high prevalence bronchitis in this region facilitates the market growth.


Asia-Pacific was projected to be the rapidly growing region for the global sinus dilation devices market . The market is expected to witness growth owing to the increasing various technological for developing sinus devices, rising of balloon sinuplasty. According to the National Center for Biotechnology Information 2015, around 107 million people were affected by chronic sinusitis in mainland China. It was also reported that chronic sinusitis was dominant among people with some medical conditions, such as asthma, allergic rhinitis, and chronic obstructive pulmonary disease.


These factors are responsible for the growth of sinus dilation devices market growth in Asia-Pacific countries.


The Middle East and Africa hold low share in the global sinus dilation devices market due to, low awareness about the advanced technology, low spending on healthcare, and low economic countries. However, the sinus dilation devices market is expected to witness growth due to increasing government regulation related to hospital sanitation and patient care in the Middle East.  

Recent Development


Sklar has the biggest collection of surgical instruments in the US (over 19,000 SKUs), as well as a lifetime warranty, competitive pricing, and same-day shipping. Choosing the correct instrument for the job will help you save money while still offering high-quality service. Finding all of your instrument options under one roof might be difficult, but Sklar has a wide selection of instrument lines to fit your needs. Sklar has a long history of supplying outstanding, high-quality equipment to the medical, dental, and veterinary sectors.


Bausch & Lomb Inc (Bausch & Lomb) is a vision-care firm that focuses on the protection, enhancement, and restoration of eyesight. It is a subsidiary of Bausch Health Companies Inc. It sells over-the-counter vitamins, contact lenses, ocular medications, lens care products, and ophthalmic surgery tools and devices. Conjunctivitis, glaucoma, eye allergies, dry eye, and retinal illnesses are among the problems for which the firm develops, produces, and promotes eye health products. The company's headquarters are in Bridgewater, New Jersey.


Sinus Dilation Devices Market Segmentation 


By Product



  • Balloon Dilation

  • Sinus Stents

  • Endoscope

    • Rhinoscopy

    • Sinoscopy





  • Functional endoscopic sinus surgery (FESS) instruments set

  • Handheld instruments


By Procedure  



  • Hybrid Sinus Dilation Procedures  

  • Standalone Sinus Dilation Procedures


 By Patient Type



  • Pediatric

  • Adult


 By End-Users



  • Hospitals and clinics

  • Diagnostic centers

  • ENT clinics

  • Research centers

  • Others


 By Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa


Intended Audience



  • Hospitals

  • Clinical Centers

  • Ambulatory Surgical Centers

  • Diagnostic Centers



Report Scope:

Report Attribute/Metric Details
  Market Size   2020-2027: USD 5,777.5 million
  CAGR   2020-2027: 8.5%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Procedure, Patient Type And End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Sklar Surgical Instruments (US), Accurate Surgical & Scientific Instruments (USA), Bausch & Lomb Incorporated (US), Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), Olympus Corporation (Japan), Meril Life, Sciences Pvt. Ltd. (India), SinuSys Corporation (US), Jilin Coronado Medical Ltd. (China)
  Key Market Opportunities

  • Increasing various technological for developing sinus devices
  • Rising of balloon sinuplasty
  •   Key Market Drivers

  • Prevalence of chronic sinusitis
  • Growing respiratory tract infection
  • Increase in preference for minimally invasive surgeries by the patients
  • High number of sinus patients


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The sinus dilation devices market is projected to grow at an 8.5% CAGR between 2020-2027.

    key players in the global sinus dilation devices market are Sklar Surgical Instruments (US), Accurate Surgical & Scientific Instruments (USA), Bausch & Lomb Incorporated (US), Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT

    The sinus dilation devices market predicted to touch USD 5,777.5 million by 2027.

    North America is projected to command the largest share in the sinus dilation devices market.

    Increasing respiratory tract infection and prevalence of chronic sinusitis are boosting market growth.

    Preference for drugs over surgeries may limit the market growth.